WHO: Ebola vaccine trials to begin in Democratic Republic of Congo next week

WHO announces start of trials for two Ebola vaccines in the Democratic Republic of Congo next week
Translated by Alqyas from Kuwait News — Original source
The World Health Organization (WHO) announced on Tuesday that two candidate vaccines against a strain of the Ebola virus spreading in the Democratic Republic of Congo will enter the trial phase at the outbreak epicenter next week.
WHO figures indicate that 11,376 infections and 5,568 deaths have been recorded due to the Ebola outbreak in this vast Central African country.
WHO Director-General Tedros Adhanom Ghebreyesus said at a press conference in Geneva, “We expect that testing of two candidate vaccines, specifically developed to confront the Bundibugyo virus, will begin as soon as possible, perhaps by next week.”
The Democratic Republic of Congo officially declared the Ebola outbreak on May 15.
The current epidemic is caused by the Bundibugyo strain of the virus, for which there is currently no approved vaccine or treatment.
Tedros noted that between 400 and 500 new cases are still being recorded each week, while two-thirds of confirmed deaths still occur outside treatment centers.